3690:HKEXMeituan Class B Analysis
Data as of 2026-09-06 - not real-time
HK$81.75
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
The moving-average structure behind Meituan is neutral at HKD 81.75, with no clear ordering between short and long averages. The last 30 days have lost 5.7%. With RSI at 47.6 the momentum picture is neutral, alongside a bearish MACD signal. Watch HKD 74.45 as support and HKD 96.45 as the nearer resistance level.
The shares look undervalued at 17.0 times earnings, though no sector average was available for comparison. Consensus targets land 32.7% above where the shares trade now. Revenue is growing at 13.9% on a -10.0% profit margin.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 37.3%, a beta of 0.34 and a maximum drawdown of 39.6%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
The shares look undervalued at 17.0 times earnings, though no sector average was available for comparison. Consensus targets land 32.7% above where the shares trade now. Revenue is growing at 13.9% on a -10.0% profit margin.
On a 1-10 scale the risk profile lands at 5 — moderate. With 30-day volatility of 37.3%, a beta of 0.34 and a maximum drawdown of 39.6%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 3/10
Key Factors
- Trading below the 200-day average of 87.28
- MACD momentum is negative
- 30-day price change of -5.7%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- Trading below the 200-day average of 87.28
- Analyst targets imply +32.7% versus the current price
- MACD momentum is negative
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Negative profit margin of -10.0%
- Analyst targets imply +32.7% versus the current price
- Negative return on equity of -21.8%
Key Metrics & Analysis
Financial Health
Revenue Growth13.90%
Profit Margin-10.04%
P/E Ratio17.0
ROE-21.76%
ROA-8.07%
Debt/Equity56.65
P/B Ratio2.8
Op. Cash FlowHK$-26000486400
Free Cash FlowHK$-23078008832
Technical Analysis
TrendNeutral
RSI47.6
SupportHK$74.45
ResistanceHK$96.45
MA 20HK$83.74
MA 50HK$83.41
MA 200HK$87.28
MACDBearish
VolumeIncreasing
Fear & Greed Index95.48
Valuation
Target PriceHK$108.45
Upside/Downside32.66%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.34
Volatility37.26%
Sector RiskHigh
Reg. RiskLow
Geo RiskHigh
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.